CD8A and neoplasm: In bilateral MC38 tumor-bearing mice, it was shown that CD8 T-cell depletion with an anti-CD8β mAb completely abolished 17D-induced tumor delay in those directly injected and in the contralateral tumor nodules, leading to reduced overall survival.